Sana Biotechnology, Inc. (SANA) Free cash flow 2019–2025
Sana Biotechnology, Inc. (SANA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$144.8MFY2025 · since FY2019: -$111.6M → -$144.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$144.8M | +43.6% |
| FY2024 | -$256.6M | +6.2% |
| FY2023 | -$273.6M | +12.0% |
| FY2022 | -$310.9M | -10.7% |
| FY2021 | -$280.9M | -73.6% |
| FY2020 | -$161.9M | -45.0% |
| FY2019 | -$111.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice